- Home
- ARTV vs PLUR Comparison
ARTV vs PLUR Comparison
Compare ARTV & PLUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARTV
- PLUR
- Stock Information
- Founded
- ARTV 2019
- PLUR 2001
- Country
- ARTV United States
- PLUR Israel
- Employees
- ARTV N/A
- PLUR N/A
- Industry
- ARTV
- PLUR Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ARTV
- PLUR Health Care
- Exchange
- ARTV NYSE
- PLUR Nasdaq
- Market Cap
- ARTV 39.0M
- PLUR 41.9M
- IPO Year
- ARTV 2024
- PLUR N/A
- Fundamental
- Price
- ARTV $1.61
- PLUR $5.88
- Analyst Decision
- ARTV Strong Buy
- PLUR Strong Buy
- Analyst Count
- ARTV 8
- PLUR 1
- Target Price
- ARTV $18.14
- PLUR $12.00
- AVG Volume (30 Days)
- ARTV 303.9K
- PLUR 62.9K
- Earning Date
- ARTV 08-28-2025
- PLUR 05-13-2025
- Dividend Yield
- ARTV N/A
- PLUR N/A
- EPS Growth
- ARTV N/A
- PLUR N/A
- EPS
- ARTV N/A
- PLUR N/A
- Revenue
- ARTV N/A
- PLUR $1,034,000.00
- Revenue This Year
- ARTV N/A
- PLUR $472.39
- Revenue Next Year
- ARTV N/A
- PLUR $254.29
- P/E Ratio
- ARTV N/A
- PLUR N/A
- Revenue Growth
- ARTV N/A
- PLUR 203.23
- 52 Week Low
- ARTV $1.47
- PLUR $3.33
- 52 Week High
- ARTV $17.31
- PLUR $7.13
- Technical
- Relative Strength Index (RSI)
- ARTV N/A
- PLUR 66.26
- Support Level
- ARTV N/A
- PLUR $4.61
- Resistance Level
- ARTV N/A
- PLUR $5.40
- Average True Range (ATR)
- ARTV 0.00
- PLUR 0.55
- MACD
- ARTV 0.00
- PLUR 0.13
- Stochastic Oscillator
- ARTV 0.00
- PLUR 91.46
About ARTV ARTIVA BIOTHERAPEUTICS INC
Artiva Biotherapeutics Inc is a biopharmaceutical company. The company is engaged in advancing a pipeline of off-the-shelf, allogeneic NK cell therapies for the treatment of hematologic malignancies or solid tumors. The pipeline program of the company includes Artiva-Funded Trials and Collaborator-Funded Trials. The company pipeline includes AlloNK: is an allogeneic, off-the-shelf, cryopreserved NK cell therapy candidate designed to enhance the antibody-dependent cellular cytotoxicity (ADCC) effect of mAbs to drive B-cell. Others products includes: CAR-NK(AB201),CAR-NK(AB205).
About PLUR Pluri Inc.
Pluri Inc is a biotechnology company, that creates cell-based products for commercial use and is pioneering a biotech revolution that promotes wellbeing and sustainability. The company's technology platform developed a three-dimensional, or 3D, technology platform for cell expansion with an industrial scale in-house Good Manufacturing Practice, or GMP, cell manufacturing facility. It uses its technology in the field of regenerative medicine, food tech and agricultural technology or agtech.